Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

NCT: NCT03911700 · RECRUITING

NCT IDNCT03911700
StatusRECRUITING
Start Date2019-12-12
Completion2031-12
SponsorC. R. Bard (INDUSTRY)
First posted
Last updated

Brief Summary

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surgery.

Frequently Asked Questions

What is Prophylactic Reinforcement of Ventral Abdominal Incisions Trial?

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial is a clinical trial registered under NCT03911700. Current status: RECRUITING.

What is the status of NCT03911700?

The current status of NCT03911700 (Prophylactic Reinforcement of Ventral Abdominal Incisions Trial) is: RECRUITING.

When did Prophylactic Reinforcement of Ventral Abdominal Incisions Trial start?

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial started on 2019-12-12.

Related Devices

K190185Phasix ST Mesh with Open Positioning SystemC.R. Bard, Inc. K151985PowerPICC® EtOH Catheter and PowerPICC SOLO®2 EtOH CatheterC.R. Bard, Inc. K152136Recovery Cone Removal SystemC.R. Bard, Inc. K152613True Flow Valvuloplasty Perfusion CatheterC.R. Bard, Inc. K153190Zenysis Short-Term Dialysis CatheterC.R. Bard, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑